Why is Medi Assist Ser. falling/rising?

Recent Price Movements and Market Context

The stock has been under pressure for five consecutive trading sessions, losing 7.72% over the past week, while the broader Sensex remained virtually flat with a marginal gain of 0.02%. Despite opening the day with a positive gap of 2.01% and touching an intraday high of ₹472.85, the stock ultimately succumbed to selling pressure, closing near its intraday low. This pattern suggests that initial optimism was outweighed by bearish sentiment as the trading day progressed.

Further compounding the negative outlook, the weighted average price indicates that a greater volume of shares traded closer to the lower end of the day’s price range, signalling stronger selling interest. Additionally, Medi Assist Healthcare Services Ltd is trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – underscoring a sustained downtrend and weak technical positioning.

Investor participation has also waned, with delivery volumes on 15 Dec falling by 35.6% compared to the five-day average, reflecting reduced conviction among shareholders and possibly a reluctance to accumulate shares amid uncertainty.

Fundamental Challenges Weighing on the Stock

While Medi Assist Healthcare Services Ltd boasts a respectable long-term Return on Equity (ROE) of 14.05%, signalling solid fundamental strength, recent financial indicators reveal troubling signs. Interest expenses for the nine-month period have surged by 182.12% to ₹16.73 crores, exerting pressure on profitability. The operating profit to interest ratio has dropped to a low of 5.23 times, indicating that earnings before interest and taxes are barely sufficient to cover rising interest costs.

Moreover, profit before tax excluding other income for the latest quarter stood at ₹11.19 crores, marking a steep decline of 51.0% compared to the average of the previous four quarters. This sharp fall in core profitability raises concerns about the company’s operational efficiency and earnings quality.

Despite these challenges, the stock’s valuation remains elevated, with a price-to-book value ratio of 5.8, suggesting that investors are paying a premium relative to the company’s net asset value. Although the stock is trading at a discount compared to its peers’ historical valuations, this expensive valuation may be difficult to justify amid weakening profit metrics and subdued market sentiment.

Long-Term and Year-to-Date Performance

Over the past year, Medi Assist Healthcare Services Ltd has delivered a negative return of 27.16%, significantly underperforming the Sensex, which gained 3.59% during the same period. Year-to-date, the stock is down 22.39%, while the benchmark index has risen by 8.37%. The stock’s underperformance extends beyond the short term, as it has lagged the BSE500 index over the last three years and one year, reflecting persistent challenges in generating shareholder value.

Interestingly, despite the decline in share price, the company’s profits have increased by 5% over the past year, indicating some operational resilience. However, this improvement has not been sufficient to offset concerns about rising interest costs and deteriorating quarterly profitability, which continue to weigh on investor confidence.

Conclusion: Why the Stock is Falling

The decline in Medi Assist Healthcare Services Ltd’s share price on 16-Dec is primarily attributable to a combination of weak recent financial performance, rising interest expenses, and a challenging valuation backdrop. The stock’s consistent underperformance relative to the Sensex and BSE500 indices, coupled with falling investor participation and technical weakness, has intensified selling pressure. Although the company maintains a strong ROE and has seen modest profit growth over the past year, these positives have been overshadowed by deteriorating quarterly profitability and elevated interest costs.

Investors appear cautious, reflecting concerns about the sustainability of earnings and the company’s ability to manage its financial obligations effectively. Until there is clear evidence of improved operational performance and stabilisation of interest expenses, the stock is likely to remain under pressure in the near term.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →